Dalbavancin in Real Clinical Practice in Spain

Clinical trial NCT04485676 · COMPLETED

Trial details

NCT number: NCT04485676
Sponsor: Angelini Farmacéutica
Status: COMPLETED
Study type: OBSERVATIONAL

Skin Diseases, Bacterial Skin Diseases, Infectious

Start date: 2020-07-15
Primary completion: 2020-12-31
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.